John McNally PhD in

John McNally PhD

Senior Director, Clinical Development at Corcept Therapeutics
📍 San Mateo, California, United States

John McNally is a clinical development leader at Corcept Therapeutics with over 15 years of biopharmaceutical experience. An alumnus of Dublin City University where he earned his PhD, he specializes in immunology and infectious diseases. He has a proven track record of successfully leading complex drug programs to global approval.

He played a pivotal leadership role in the global development and approval of novel therapies, including JYSELECA® for ulcerative colitis and EPCLUSA® for HCV infection.

Read the full overview →
Experience
11 Years
Current Role
Senior Director, Clinical Development
Job Level
Senior
Location
San Mateo, California, United States
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities

Topics John cares about

Global Drug Development
He has extensive experience leading complex, cross-functional programs from pre-IND through Phase 3, resulting in successful global product approvals in the US, EU, and Japan.
Immunology & IBD
He has deep therapeutic expertise in immunology and headed the global development for JYSELECA®, a therapy for ulcerative colitis and Crohn's disease.
+5 more topics Login to view topics
Career

Work history

8-2025
Senior Director, Clinical Development
Corcept Therapeutics
3-2021 - 6-2025
Program Team Lead
Gilead Sciences
1-2017 - 3-2021
Executive Director, Clinical Research - IBD
Gilead Sciences
1-2014 - 12-2016
Director, Clinical Research
Gilead Sciences
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
Bachelor of Science - BS
Dublin City University
Doctor of Philosophy - PhD
Dublin City University
Social presence
in

Other Corcept Therapeutics Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to John. Free, 10 seconds.